Cherington Charles
Insider CIK 1448698 · CMRA 10% owner · BTX Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ERNA Ernexa Therapeutics Inc. | P Buy deriv | 2026-02-10 | 2026-02-17 | 4,000,000 | — | $0 | 4,000,000 | SEC↗ |
| ERNA Ernexa Therapeutics Inc. | P Buy | 2026-02-10 | 2026-02-17 | 4,000,000 | $0.50 | $2.00M | 6,779,440 | SEC↗ |
| ERNA Ernexa Therapeutics Inc. | P Buy | 2025-06-09 | 2025-06-11 | 21,241,163 | $0.10 | $2.12M | 41,659,743 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | P Buy | 2025-04-02 | 2025-04-04 | 3,768,397 | $0.10 | $376.8K | 20,401,602 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | S Sale deriv | 2024-10-29 | 2024-11-05 | 0 | — | $0 | 0 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | C Conversion deriv | 2024-10-29 | 2024-11-05 | 0 | — | $0 | 0 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | S Sale deriv | 2024-10-29 | 2024-11-05 | 0 | — | $0 | 0 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | S Sale deriv | 2024-10-29 | 2024-11-05 | 0 | — | $0 | 0 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | S Sale deriv | 2024-10-29 | 2024-11-05 | 0 | — | $0 | 0 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | S Sale deriv | 2024-10-29 | 2024-11-05 | 0 | — | $0 | 0 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | P Buy | 2024-10-29 | 2024-11-05 | 261,756 | — | $0 | 818,221 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | P Buy | 2024-10-29 | 2024-11-05 | 5,420,823 | — | $0 | 12,245,589 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | P Buy | 2024-10-29 | 2024-11-05 | 1,237,762 | — | $0 | 6,824,766 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | P Buy | 2024-10-29 | 2024-11-05 | 4,768,783 | — | $0 | 5,587,004 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | C Conversion | 2024-10-29 | 2024-11-05 | 2,819,546 | $0.50 | $1.41M | 16,628,123 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | P Buy | 2024-10-29 | 2024-11-05 | 1,562,988 | — | $0 | 13,808,577 | SEC↗ |
| ERNA Ernexa Therapeutics Inc. | S Sale deriv | 2024-09-24 | 2025-05-07 | 3,125,976 | — | $0 | 0 | SEC↗ |
| ERNA Ernexa Therapeutics Inc. | S Sale deriv | 2024-09-24 | 2025-05-07 | 0 | — | $0 | 0 | SEC↗ |
| ERNA Ernexa Therapeutics Inc. | S Sale deriv | 2024-09-24 | 2025-05-07 | 0 | — | $0 | 0 | SEC↗ |
| ERNA Ernexa Therapeutics Inc. | S Sale deriv | 2024-09-24 | 2025-05-07 | 523,512 | — | $0 | 0 | SEC↗ |
| ERNA Ernexa Therapeutics Inc. | S Sale deriv | 2024-09-24 | 2025-05-07 | 2,475,524 | — | $0 | 0 | SEC↗ |
| ERNA Ernexa Therapeutics Inc. | P Buy | 2024-09-24 | 2025-05-07 | 261,756 | — | $0 | 818,221 | SEC↗ |
| ERNA Ernexa Therapeutics Inc. | P Buy | 2024-09-24 | 2025-05-07 | 4,768,783 | — | $0 | 5,587,004 | SEC↗ |
| ERNA Ernexa Therapeutics Inc. | P Buy | 2024-09-24 | 2025-05-07 | 1,237,762 | — | $0 | 6,824,766 | SEC↗ |
| ERNA Ernexa Therapeutics Inc. | P Buy | 2024-09-24 | 2025-05-07 | 5,420,823 | — | $0 | 12,245,589 | SEC↗ |
| ERNA Ernexa Therapeutics Inc. | P Buy | 2024-09-24 | 2025-05-07 | 1,562,988 | — | $0 | 13,808,577 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | P Buy deriv | 2024-09-24 | 2024-11-05 | 3,125,976 | $1368626.00 | $4278.29B | 0 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | P Buy deriv | 2024-09-23 | 2024-11-05 | 83,916 | — | $0 | 2,391,608 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | P Buy deriv | 2024-09-23 | 2024-11-05 | 83,916 | — | $0 | 2,475,524 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | P Buy deriv | 2024-09-23 | 2024-11-05 | 523,512 | — | $0 | 0 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | P Buy deriv | 2024-09-23 | 2024-11-05 | 2,475,524 | — | $0 | 0 | SEC↗ |
| CMRA Comera Life Sciences Holdi | P Buy deriv | 2023-12-29 | 2024-01-03 | 3,896 | — | $0 | 3,896 | SEC↗ |
| CMRA Comera Life Sciences Holdi | P Buy deriv | 2023-12-29 | 2024-01-03 | 20,650,908 | $567900.00 | $11727.65B | 20,650,908 | SEC↗ |
| CMRA Comera Life Sciences Holdi | P Buy deriv | 2023-12-27 | 2024-01-03 | 0 | $500000.00 | $0 | 0 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | H Expire deriv | 2023-12-14 | 2023-12-20 | 2,307,692 | — | $0 | 2,307,692 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | P Buy deriv | 2023-12-14 | 2023-12-20 | 3,125,976 | $3000000.00 | $9377.93B | 3,125,976 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | H Expire deriv | 2023-12-14 | 2023-12-20 | 523,512 | — | $0 | 523,512 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | P Buy deriv | 2023-12-14 | 2023-12-20 | 523,512 | — | $0 | 0 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | P Buy deriv | 2023-12-14 | 2023-12-20 | 0 | — | $0 | 0 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | P Buy deriv | 2023-12-14 | 2023-12-20 | 2,307,692 | $0.13 | $300.0K | 0 | SEC↗ |
| CMRA Comera Life Sciences Holdi | P Buy deriv | 2023-09-11 | 2023-09-11 | 5,134,474 | — | $0 | 5,134,474 | SEC↗ |
| CMRA Comera Life Sciences Holdi | P Buy | 2023-09-11 | 2023-09-11 | 2,053,789 | $0.51 | $1.05M | 5,813,650 | SEC↗ |
| CMRA Comera Life Sciences Holdi | P Buy deriv | 2023-07-31 | 2023-08-25 | 2,200,488 | — | $0 | 2,200,488 | SEC↗ |
| CMRA Comera Life Sciences Holdi | P Buy | 2023-07-31 | 2023-08-25 | 880,195 | $0.51 | $448.9K | 3,759,861 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | P Buy deriv | 2023-07-13 | 2023-08-25 | 0 | $0.13 | $0 | 0 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | P Buy deriv | 2023-07-13 | 2023-08-25 | 2,307,692 | $3300000.00 | $7615.38B | 2,307,692 | SEC↗ |
| CMRA Comera Life Sciences Holdi | P Buy deriv | 2023-01-04 | 2023-01-06 | 743,243 | $0.25 | $185.8K | 743,243 | SEC↗ |
| CMRA Comera Life Sciences Holdi | P Buy | 2023-01-04 | 2023-01-06 | 743,243 | $1.23 | $914.2K | 2,879,666 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | P Buy deriv | 2022-12-02 | 2022-12-06 | 523,512 | $0.13 | $68.1K | 523,512 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | P Buy | 2022-12-02 | 2022-12-06 | 261,756 | $3.28 | $858.6K | 556,465 | SEC↗ |
| CMRA Comera Life Sciences Holdi | P Buy | 2022-10-21 | 2022-10-24 | 11,691 | $1.59 | $18.6K | 649,937 | SEC↗ |
| CMRA Comera Life Sciences Holdi | P Buy | 2022-10-20 | 2022-10-24 | 3,316 | $1.52 | $5.0K | 638,246 | SEC↗ |
| CMRA Comera Life Sciences Holdi | P Buy | 2022-10-17 | 2022-10-18 | 15,266 | $1.66 | $25.3K | 634,930 | SEC↗ |
| CMRA Comera Life Sciences Holdi | P Buy | 2022-10-14 | 2022-10-18 | 4,253 | $1.60 | $6.8K | 619,664 | SEC↗ |
| CMRA Comera Life Sciences Holdi | P Buy | 2022-10-13 | 2022-10-14 | 10,481 | $1.66 | $17.4K | 615,411 | SEC↗ |
| CMRA Comera Life Sciences Holdi | P Buy | 2022-09-29 | 2022-09-30 | 17,900 | $1.87 | $33.5K | 604,930 | SEC↗ |
| CMRA Comera Life Sciences Holdi | P Buy | 2022-09-27 | 2022-09-29 | 12,000 | $1.69 | $20.3K | 587,030 | SEC↗ |
| BTX Brooklyn ImmunoTherapeutic | A Award deriv | 2022-08-01 | 2022-08-03 | 165,800 | — | $0 | 165,800 | SEC↗ |
| BTX Brooklyn ImmunoTherapeutic | A Award deriv | 2022-08-01 | 2022-08-03 | 215,100 | — | $0 | 215,100 | SEC↗ |
| BTX Brooklyn ImmunoTherapeutic | A Award deriv | 2021-12-08 | 2021-12-10 | 67,000 | — | $0 | 67,000 | SEC↗ |
| BTX Brooklyn ImmunoTherapeutic | S Sale | 2021-06-17 | 2021-06-21 | 198,000 | $15.74 | $3.12M | 5,896,101 | SEC↗ |
| BTX Brooklyn ImmunoTherapeutic | S Sale | 2021-06-17 | 2021-06-21 | 2,000 | $16.30 | $32.6K | 5,894,101 | SEC↗ |
| BTX Brooklyn ImmunoTherapeutic | S Sale | 2021-06-16 | 2021-06-21 | 200,000 | $15.73 | $3.15M | 6,094,101 | SEC↗ |
| BTX Brooklyn ImmunoTherapeutic | J Other | 2021-06-01 | 2021-12-10 | 92 | — | $0 | 5,894,193 | SEC↗ |